Niagen Bioscience (NAGE) Total Debt (2016 - 2018)

Niagen Bioscience (NAGE) posted quarterly Total Debt of $137000.0 for Q4 2018, down 55.81% year-over-year from $310000.0 in Q4 2017, and down 55.81% quarter-over-quarter from $310000.0 in Q4 2017.

Niagen Bioscience (NAGE) Total Debt (2016 - 2018) Analysis & Trends

Niagen Bioscience (NAGE) has reported Total Debt for 3 consecutive years, with $137000.0 the latest figure, recorded in Q4 2018.

  • In Q4 2018, Total Debt fell 55.81% year-over-year to $137000.0; the TTM figure through Dec 2018 stood at $137000.0 (down 55.81% YoY), while the FY2018 annual figure was $137000.0, down 55.81% from the prior year.
  • Total Debt eased to $137000.0 in Q4 2018 per NAGE's latest filing, from $310000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $4.9 million in Q1 2016 and bottomed at $137000.0 in Q4 2018.
  • Historically, Total Debt has averaged $1.4 million across 3 years, with a median of $327000.0 in 2016.
  • Annual changes were most pronounced in 2016 — Total Debt sank 92.94% — and 2017, when it decreased 9.88%.
  • Niagen Bioscience's Total Debt stood at $344000.0 in 2016, then retreated by 9.88% to $310000.0 in 2017, then tumbled by 55.81% to $137000.0 in 2018.
  • Business Quant data shows NAGE's Total Debt at $137000.0 in Q4 2018, $310000.0 in Q4 2017, and $344000.0 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.07 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.34 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 546.77 Mn
10 Niagen Bioscience 238.30 Mn 171.56 Mn 19.31 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 137,000.00
Dec 30, 2017 310,000.00
Dec 31, 2016 344,000.00
Jan 2, 2016 4.87 Mn